You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-transplantation cyclophosphamide

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD Trial in Shenzhen, Shanghai (PTCY)

Not yet recruiting
  • GVHD
  • Shenzhen, GaungDong, China
  • +1 more
Aug 17, 2023

Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)

Enrolling by invitation
  • Graft Vs Host Disease
  • Puebla, Mexico
    Centro de Hematología y Medicina Interna
Mar 22, 2023

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

Recruiting
  • Haploidentical Hematopoietic Stem Cell Transplantation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 11, 2023

The Optimization of Haploidentical Hematopoietic Stem Cell

Not yet recruiting
  • Hematological Malignancy
  • ATG
  • Post-transplantation cyclophosphamide
  • Beijing, Beijing, China
    People's Hospital of Peking University
Nov 28, 2022

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • (no location specified)
Jun 6, 2023

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)

Recruiting
  • GVHD
  • Hematologic Neoplasms
  • La Jolla, California
    UC San Diego Moores Cancer Center
Mar 21, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bone Marrow Hematopoeitic Cell Transplant (HCT)
  • +9 more
  • (no location specified)
Sep 27, 2021

GVHD, Hematologic Malignancy, Cyclophosphamide Adverse Reaction Trial (Post-transplantation Cyclophosphamide at dose 25

Not yet recruiting
  • Graft Versus Host Disease
  • +2 more
  • Post-transplantation Cyclophosphamide at dose 25 mg/kg/day
  • Post-transplantation Cyclophosphamide at dose 50 mg/kg/day
  • (no location specified)
Dec 17, 2021

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

Not yet recruiting
  • Bone Marrow Transplant Complications
  • +4 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

Not yet recruiting
  • GATA2
  • Immunodeficiency
  • Mycophenolate Mofetil
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

Suspended
  • Hematologic Malignancies
  • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
  • La Jolla, California
    UCSD Medical Center
Jul 20, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Graft-versus-Host Disease Trial in Cologne (Everolimus)

Completed
  • Graft-versus-Host Disease
  • Cologne, Germany
    University of Cologne
Mar 16, 2021